The Hôpital Cochin is a hospital of public assistance in the rue du Faubourg-Saint-Jacques Paris 14e. It houses the central burn treatment centre of the city. The Hôpital Cochin is a section of the Faculté de Médecine Paris-Descartes.

During the past decade, Hopital Cochin conducted 418 clinical trials. In the 10-year time frame, 418 clinical trials started and 67 clinical trials were completed, i.e. on average, 16% percent of trials that started reached the finish line to date. In the past 5 years, 198 clinical trials started and 49 clinical trials were completed. i.e. 24.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hopital Cochin" #1 sponsor was "Assistance Publique - Hôpitaux de Paris" with 152 trials, followed by "Groupe Francophone des Myelodysplasies" with 18 trials sponsored, "ARCAGY/ GINECO GROUP" with 14 trials sponsored, "Pfizer" with 13 trials sponsored and "European Organisation for Research and Treatment of Cancer - EORTC" with 13 trials sponsored. Other sponsors include 426 different institutions and companies that sponsored additional 201 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hopital Cochin" #1 collaborator was "Ministry of Health, France" with 18 trials as a collaborator, "Institut National de la Santé Et de la Recherche Médicale, France" with 17 trials as a collaborator, "National Cancer Institute, France" with 10 trials as a collaborator, "Roche Pharma AG" with 8 trials as a collaborator and "Assistance Publique - Hôpitaux de Paris" with 6 trials as a collaborator. Other collaborators include 388 different institutions and companies that were collaborators in the rest 296 trials.

According to Clinical.Site data, the most researched conditions in "Hopital Cochin" are "Cystic Fibrosis" (26 trials), "Myelodysplastic Syndromes" (12 trials), "COVID-19" (10 trials), "Rheumatoid Arthritis" (10 trials) and "Colorectal Cancer" (9 trials). Many other conditions were trialed in "Hopital Cochin" in a lesser frequency.

Most popular intervention types in "Hopital Cochin" are "Drug" (334 trials), "Other" (123 trials), "Procedure" (73 trials), "Biological" (49 trials) and "Device" (46 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (63 trials), "placebo" (15 trials), "Gemcitabine" (10 trials), "Rituximab" (9 trials) and "Carboplatin" (8 trials). Other intervention names were less common.

The vast majority of trials in "Hopital Cochin" are 561 trials for "All" genders, 57 trials for "Female" genders and 22 trials for "Male" genders.

Currently, there are NaN active trials in "Hopital Cochin". 14 are not yet recruiting, 134 are recruiting, 46 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 332 completed trials in Hopital Cochin, 3 suspended trials, and 53 terminated clinical trials to date.

Out of the total trials that were conducted in Hopital Cochin, 24 "Phase 1" clinical trials were conducted, 145 "Phase 2" clinical trials and 189 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 30 trials, and there were also 135 trials that are defined as “Not Applicable".